Project Number GC-2013537 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Testing of selective DYRK1A inhibitors as a novel treatment for AD - ADD ON Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Dunckley, Travis Principal Investigator First Name Travis Principal Investigator Last Name Dunckley Awardee Organization Arizona State University Foundation Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $26,401 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
